LTA4H regulates cell cycle and skin carcinogenesis

Naomi Oi, Hiroyuki Yamamoto, Alyssa Langfald, Ruihua Bai, Mee Hyun Lee, Ann M. Bode, Zigang Dong

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Leukotriene A4 hydrolase (LTA4H), a bifunctional zinc metallo-enzyme, is reportedly overexpressed in several human cancers. Our group has focused on LTA4H as a potential target for cancer prevention and/or therapy. In the present study, we report that LTA4H is a key regulator of cell cycle at the G0/G1 phase acting by negatively regulating p27 expression in skin cancer. We found that LTA4H is overexpressed in human skin cancer tissue. Knocking out LTA4H significantly reduced skin cancer development in the 7,12-dimethylbenz(a)anthracene (DMBA)-initiated/12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted two-stage skin cancer mouse model. LTA4H depletion dramatically decreased anchorage-dependent and -independent skin cancer cell growth by inducing cell cycle arrest at the G0/G1 phase. Moreover, our findings showed that depletion of LTA4H enhanced p27 protein stability, which was associated with decreased phosphorylation of CDK2 at Thr160 and inhibition of the CDK2/cyclin E complex, resulting in down-regulated p27 ubiquitination. These findings indicate that LTA4H is critical for skin carcinogenesis and is an important mediator of cell cycle and the data begin to clarify the mechanisms of LTA4H's role in cancer development.

Original languageEnglish (US)
Article numberbgx049
Pages (from-to)728-737
Number of pages10
Issue number7
StatePublished - Jul 1 2017

Bibliographical note

Publisher Copyright:
© The Author 2017. Published by Oxford University Press. All rights reserved.


Dive into the research topics of 'LTA4H regulates cell cycle and skin carcinogenesis'. Together they form a unique fingerprint.

Cite this